Italy
· Delayed Price · Currency is EUR Mycronic AB Statistics
Total Valuation
Mycronic AB has a market cap or net worth of EUR 3.86 billion. The enterprise value is 3.60 billion.
| Market Cap | 3.86B |
| Enterprise Value | 3.60B |
Important Dates
The last earnings date was Tuesday, April 1, 2025.
| Earnings Date | Apr 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 74.78M |
Valuation Ratios
The trailing PE ratio is 26.26.
| PE Ratio | 26.26 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 11.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.99, with an EV/FCF ratio of 23.62.
| EV / Earnings | 24.53 |
| EV / Sales | 5.51 |
| EV / EBITDA | 16.99 |
| EV / EBIT | 19.23 |
| EV / FCF | 23.62 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.15 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.13 |
| Interest Coverage | 134.87 |
Financial Efficiency
Return on equity (ROE) is 28.47% and return on invested capital (ROIC) is 20.55%.
| Return on Equity (ROE) | 28.47% |
| Return on Assets (ROA) | 13.49% |
| Return on Invested Capital (ROIC) | 20.55% |
| Return on Capital Employed (ROCE) | 28.07% |
| Revenue Per Employee | 285,403 |
| Profits Per Employee | 68,065 |
| Employee Count | 2,158 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 29.57 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mycronic AB had revenue of EUR 615.90 million and earned 146.88 million in profits. Earnings per share was 1.50.
| Revenue | 615.90M |
| Gross Profit | 324.75M |
| Operating Income | 176.56M |
| Pretax Income | 181.88M |
| Net Income | 146.88M |
| EBITDA | 199.77M |
| EBIT | 176.56M |
| Earnings Per Share (EPS) | 1.50 |
Balance Sheet
The company has 263.05 million in cash and 19.20 million in debt, giving a net cash position of 243.85 million.
| Cash & Cash Equivalents | 263.05M |
| Total Debt | 19.20M |
| Net Cash | 243.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 573.83M |
| Book Value Per Share | 5.84 |
| Working Capital | 320.56M |
Cash Flow
In the last 12 months, operating cash flow was 163.55 million and capital expenditures -11.00 million, giving a free cash flow of 152.56 million.
| Operating Cash Flow | 163.55M |
| Capital Expenditures | -11.00M |
| Free Cash Flow | 152.56M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.73%, with operating and profit margins of 28.67% and 23.85%.
| Gross Margin | 52.73% |
| Operating Margin | 28.67% |
| Pretax Margin | 29.53% |
| Profit Margin | 23.85% |
| EBITDA Margin | 32.44% |
| EBIT Margin | 28.67% |
| FCF Margin | 24.77% |
Dividends & Yields
Mycronic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.20% |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 3.81% |
| FCF Yield | 3.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |